Why PMV Pharmaceuticals Inc (PMVP) Stock Is Rising
As of 2026-09-10, PMV Pharmaceuticals Inc (PMVP) has a next-year EPS growth estimate of 25.10%. Featured in our EPS revision report on 2026-09-10.
Why PMVP Stock Is Rising
- ·Current-Year Growth: Projected at 19.26%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 25.10%
- EPS growth this year
- 19.26%
- EPS next quarter (est)
- -$0.34
- Last price
- $1.44
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-10 | 25.10% | 19.26% | -$0.34 | $1.44 |
| 2026-09-09 | 25.10% | 19.26% | -$0.34 | $1.38 |
| 2026-09-08 | 25.10% | 19.26% | -$0.34 | $1.34 |
| 2026-09-07 | 25.10% | 19.26% | -$0.34 | $1.29 |
| 2026-09-06 | 25.10% | 19.26% | -$0.34 | $1.29 |
| 2026-09-04 | 25.10% | 19.26% | -$0.34 | $1.29 |
| 2026-05-12 | 25.71% | -2.48% | -$0.41 | $1.43 |
| 2026-05-11 | 26.11% | -6.08% | -$0.41 | $1.39 |
| 2026-05-10 | 26.11% | -6.08% | -$0.41 | $1.41 |
| 2026-05-07 | 26.11% | -6.08% | -$0.41 | $1.42 |
| 2026-05-06 | 26.11% | -6.08% | -$0.41 | $1.45 |
| 2026-05-05 | 26.11% | -6.08% | -$0.41 | $1.37 |
| 2026-05-04 | 26.11% | -6.08% | -$0.41 | $1.40 |
| 2026-05-03 | 26.11% | -6.08% | -$0.41 | $1.39 |
| 2026-04-30 | 26.11% | -6.08% | -$0.41 | $1.39 |
| 2026-04-29 | 26.11% | -6.08% | -$0.41 | $1.39 |
| 2026-04-28 | 26.11% | -6.08% | -$0.41 | $1.42 |
| 2026-04-27 | 26.11% | -6.08% | -$0.41 | $1.44 |
| 2026-04-26 | 26.11% | -6.08% | -$0.41 | $1.44 |
| 2026-04-24 | 26.11% | -6.08% | -$0.41 | $1.44 |
| 2026-04-23 | 26.11% | -6.08% | -$0.41 | $1.43 |
| 2026-04-22 | 26.11% | -6.08% | -$0.41 | $1.48 |
| 2026-04-21 | 26.11% | -6.08% | -$0.41 | $1.46 |
| 2026-04-20 | 26.11% | -6.08% | -$0.41 | $1.43 |
| 2026-04-19 | 26.11% | -6.08% | -$0.41 | $1.38 |
| 2026-04-16 | 26.11% | -6.08% | -$0.41 | $1.37 |
| 2026-04-15 | 26.11% | -6.08% | -$0.41 | $1.41 |
| 2026-04-14 | 26.11% | -6.08% | -$0.41 | $1.47 |
| 2026-04-13 | 26.11% | -6.08% | -$0.41 | $1.35 |
| 2026-04-12 | 26.11% | -6.08% | -$0.41 | $1.32 |
Reports Featuring PMVP
Screen Performance
Aggregate stats across all 2034 tickers our top-EPS-revision screen has flagged over the past 162 days.
- Median return since detection
- +0.7%
- % of tickers in the green
- 51%
- Median return on winners
- +20.8%
- Large revisions captured
- 1697
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did PMV Pharmaceuticals Inc (PMVP) stock go up recently?▾
PMV Pharmaceuticals Inc (PMVP) stock has risen following an analyst upgrade of its next-year EPS growth estimate on 2026-09-04. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is PMV Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-09-10, PMV Pharmaceuticals Inc (PMVP) has a next-year EPS growth estimate of 25.10%, based on analyst consensus.
When was the latest EPS estimate revision for PMVP?▾
The most recent revision occurred on 2026-09-04, when analysts adjusted the next-year EPS growth estimate from 25.71% to 25.10%.
What sector and industry does PMV Pharmaceuticals Inc belong to?▾
PMV Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PMVP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. PMV Pharmaceuticals Inc (PMVP) appears here because it was detected by our daily top-EPS-revision-performer screen.